Related Experiment Videos
Relevance of DNA-ploidy as a prognostic instrument for solid tumors
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
New biomarkers to predict the evolution of in situ breast cancers.
BioMed research international·2014
Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanoma.
International journal of oncology·2011
P53 and cathepsin-d are independent of established prognostic factors in breast-cancer.
International journal of oncology·2011
Relevance of cell kinetic and ploidy characteristics for the thermal response of malignant-melanoma primary cultures.
International journal of oncology·2011
Biological markers in transurethral biopsies from bladder-cancer - preliminary-results.
International journal of oncology·2011
Combined effects of lonidamine and tamoxifen in human breast-cancer cell-lines.
International journal of oncology·2011
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026